BPG is committed to discovery and dissemination of knowledge
- Number of total visits
-
33031216
- Number of visits today
- 7593
- Number of downloads
-
16219873
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Лукач Е, Захарцева Л, Сережко Ю, Клочков Є. ОПТИМІЗАЦІЯ ВИБОРУ БІЛКОВИХ ОНКОМАРКЕРІВ ПРИ ПЛАНУВАННІ ЛІКУВАННЯ ТА ПРОГНОЗУВАННІ ПЕРЕБІГУ ЗАХВОРЮВАННЯ ХВОРИХ НА РАК ГОРТАНІ. GoS 2022. [DOI: 10.36074/grail-of-science.28.10.2022.044] [Reference Citation Analysis]
|
2 |
Fisher ML, Balinth S, Mills AA. ΔNp63α in cancer: importance and therapeutic opportunities. Trends Cell Biol 2022:S0962-8924(22)00194-5. [PMID: 36115734 DOI: 10.1016/j.tcb.2022.08.003] [Reference Citation Analysis]
|
3 |
Fu Y, Tian G, Zhang Z, Yang X. SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC. Cancer Cell Int 2021;21:696. [PMID: 34930262 DOI: 10.1186/s12935-021-02394-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
4 |
Abdullah O, Omran Z, Hosawi S, Hamiche A, Bronner C, Alhosin M. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex. Genes (Basel) 2021;12:622. [PMID: 33922029 DOI: 10.3390/genes12050622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345